Skip to content
healthcare.dev

Glimepiride

NDC 16571-775, Glimepiride, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-775
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202759
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIMEPIRIDE4 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
16571-775-0116571077501100 TABLET in 1 BOTTLE (16571-775-01)
16571-775-5016571077550500 TABLET in 1 BOTTLE (16571-775-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/48ada723-8144-497d-afd6-a8c52a1dd3ff
  • NADAC price for package 16571077501

    GET /v1/drugs/nadac/16571077501
  • NADAC price for package 16571077550

    GET /v1/drugs/nadac/16571077550

Use it

Look up 16571-775 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-775 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-775. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.